rs200751676

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_153252.5(BRWD3):​c.5101G>A​(p.Gly1701Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000715 in 1,203,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 280 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., 9 hem., cov: 22)
Exomes 𝑓: 0.00076 ( 0 hom. 271 hem. )

Consequence

BRWD3
NM_153252.5 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 0.954

Publications

0 publications found
Variant links:
Genes affected
BRWD3 (HGNC:17342): (bromodomain and WD repeat domain containing 3) The protein encoded by this gene contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene are associated with a spectrum of cognitive disabilities and X-linked macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia. [provided by RefSeq, Jul 2017]
BRWD3 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked 93
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • infantile spasms
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03294748).
BP6
Variant X-80676917-C-T is Benign according to our data. Variant chrX-80676917-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210542.
BS2
High AC in GnomAd4 at 34 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRWD3NM_153252.5 linkc.5101G>A p.Gly1701Arg missense_variant Exon 41 of 41 ENST00000373275.5 NP_694984.5 Q6RI45-1
BRWD3NM_001441339.1 linkc.4951G>A p.Gly1651Arg missense_variant Exon 40 of 40 NP_001428268.1
BRWD3XM_017029384.2 linkc.3889G>A p.Gly1297Arg missense_variant Exon 30 of 30 XP_016884873.1 Q6RI45-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRWD3ENST00000373275.5 linkc.5101G>A p.Gly1701Arg missense_variant Exon 41 of 41 1 NM_153252.5 ENSP00000362372.4 Q6RI45-1

Frequencies

GnomAD3 genomes
AF:
0.000307
AC:
34
AN:
110728
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000329
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000169
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000605
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000380
AC:
69
AN:
181491
AF XY:
0.000404
show subpopulations
Gnomad AFR exome
AF:
0.0000764
Gnomad AMR exome
AF:
0.000331
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000632
Gnomad NFE exome
AF:
0.000693
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.000756
AC:
826
AN:
1092280
Hom.:
0
Cov.:
29
AF XY:
0.000757
AC XY:
271
AN XY:
358118
show subpopulations
African (AFR)
AF:
0.0000380
AC:
1
AN:
26286
American (AMR)
AF:
0.000228
AC:
8
AN:
35112
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19348
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53996
European-Finnish (FIN)
AF:
0.000124
AC:
5
AN:
40457
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4117
European-Non Finnish (NFE)
AF:
0.000942
AC:
788
AN:
836950
Other (OTH)
AF:
0.000523
AC:
24
AN:
45890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
39
77
116
154
193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000307
AC:
34
AN:
110779
Hom.:
0
Cov.:
22
AF XY:
0.000272
AC XY:
9
AN XY:
33033
show subpopulations
African (AFR)
AF:
0.0000328
AC:
1
AN:
30450
American (AMR)
AF:
0.00
AC:
0
AN:
10402
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3512
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2583
European-Finnish (FIN)
AF:
0.000169
AC:
1
AN:
5933
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
0.000605
AC:
32
AN:
52853
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000391
Hom.:
2
Bravo
AF:
0.000325
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.000247
AC:
30

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Aug 18, 2014
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G1701R variant (also known as c.5101G>A), located in coding exon 41 of the BRWD3 gene, results from a G to A substitution at nucleotide position 5101. The glycine at codon 1701 is replaced by arginine, an amino acid with dissimilar properties. This variant was previously reported in the SNPDatabase as rs200751676. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele was absent out of 2443 total male alleles studied. This amino acid position is not conserved on species alignment. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

not specified Benign:1
Jan 29, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Conotruncal heart malformations Benign:1
Jun 21, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, X-linked 93 Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Intellectual disability Benign:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.097
T
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.033
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.95
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.71
N
REVEL
Benign
0.081
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.58
T
Polyphen
0.0010
B
Vest4
0.15
MutPred
0.33
Gain of methylation at G1701 (P = 3e-04);
MVP
0.47
MPC
0.46
ClinPred
0.043
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.10
gMVP
0.52
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200751676; hg19: chrX-79932416; API